Dr. Laxmi Mehta (@drlaxmimehta) 's Twitter Profile
Dr. Laxmi Mehta

@drlaxmimehta

Chief #Wellbeing Leader @OhioStateMed | Director #Prevention & #WomenHeart @OSUWexMed | #TheFaceOfCardiology | Tweets are my own view and not medical advice

ID: 744580640352382976

linkhttps://www.linkedin.com/in/laxmimehta/ calendar_today19-06-2016 17:20:33

7,7K Tweet

11,11K Followers

5,5K Following

Dr. Laxmi Mehta (@drlaxmimehta) 's Twitter Profile Photo

We toured the new The Ohio State University Wexner Medical Center hospital tower, it will open in 2026 Impressive building with state of the art technology elevating patient-centered care, plenty of natural light, reflective spaces & respite space, amazing views (including of The Horseshoe). #OSUWexMed The Ohio State University College of Medicine

We toured the new <a href="/OSUWexMed/">The Ohio State University Wexner Medical Center</a> hospital tower, it will open in 2026
Impressive building with state of the art technology elevating patient-centered care, plenty of natural light, reflective spaces &amp; respite space, amazing views (including of The Horseshoe).
#OSUWexMed <a href="/OhioStateMed/">The Ohio State University College of Medicine</a>
Gumina Lab (@gumina_lab) 's Twitter Profile Photo

Cardiovascular Scientists and Physician/Clinician-Scientist. We are actively expanding our research portfolio. If you would like to learn about opportunities in a growing vibrant academic cardiovascular medicine program please contact me directly at [email protected]

Amit Khera (@dramitkhera) 's Twitter Profile Photo

We are 40 days away from #AHA2024 and the first #LateBreaker session. 8 LBS sessions in all covering #Innovation #HFPEF #HF #AI #Ablation #Afib #ACS #Lipids #Surgery #GLP1RA #HTN #globalhealth Don’t miss these practice changing sessions and the #AHA100th anniversary AHA Science

We are 40 days away from #AHA2024 and the first #LateBreaker session. 8 LBS sessions in all covering #Innovation #HFPEF #HF #AI #Ablation #Afib #ACS #Lipids #Surgery #GLP1RA #HTN #globalhealth Don’t miss these practice changing sessions and the #AHA100th anniversary  <a href="/AHAScience/">AHA Science</a>
AHA Science (@ahascience) 's Twitter Profile Photo

📣Announcing Scientific Sessions 2024 Late-Breaking Science 📣 Join us in November to experience the highest tier of scientific discovery and practice-changing educational content. Amit Khera Jo Chikwe

📣Announcing Scientific Sessions 2024 Late-Breaking Science 📣

Join us in November to experience the highest tier of scientific discovery and practice-changing educational content.

<a href="/dramitkhera/">Amit Khera</a> <a href="/JoChikweMD/">Jo Chikwe</a>
American College of Cardiology (@accintouch) 's Twitter Profile Photo

Did you know that your #mentalhealth can have a major impact on your #hearthealth? For #WorldMentalHealthDay 🌎🧠, the ACC and Dr. Laxmi Mehta want to remind you of the importance of seeking help for yourself and/or others. Read more on how to get help here ➡️

Dr. Laxmi Mehta (@drlaxmimehta) 's Twitter Profile Photo

Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity Standing room only at #AHA24 In-Depth session on the Summit Trial. AHA Science nejm.org/doi/full/10.10…

Dr. Laxmi Mehta (@drlaxmimehta) 's Twitter Profile Photo

DAPT in Women Post-PCI by George Dangas, MD, MACC, MSCAI Women with increased bleeding risk and ischemic events. Similar bleeding risk reduction and potentially greater ischemic risk reduction in women. #AHA24 AHA Science Dr Roxana Mehran Janet Wei MD

DAPT in Women Post-PCI by <a href="/georgedangas/">George Dangas, MD, MACC, MSCAI</a> 
Women with increased bleeding risk and ischemic events. Similar bleeding risk reduction and potentially greater ischemic risk reduction in women. #AHA24 <a href="/AHAScience/">AHA Science</a> <a href="/Drroxmehran/">Dr Roxana Mehran</a> <a href="/JanetWeiMD/">Janet Wei MD</a>
Ritu Thamman MD (@iamritu) 's Twitter Profile Photo

#CLEAR #AHA24 More than inflammation matters post MI In early post-MI patients (within 42hrs of MI): Despite CRP reduction, colchicine did NOT reduce cv events (9.1% colchicine 🆚9.3% placebo (P=0.93) Caveat:1/4 patients discontinued colchicine bit.ly/4eIK26Y

#CLEAR #AHA24
More than inflammation matters post MI 

In early post-MI patients (within 42hrs of MI):

Despite CRP reduction, 
colchicine did NOT reduce cv events (9.1% colchicine 🆚9.3% placebo (P=0.93)

Caveat:1/4 patients discontinued colchicine bit.ly/4eIK26Y
Dr. Laxmi Mehta (@drlaxmimehta) 's Twitter Profile Photo

Reconditioned pacemaker devices using an FDA-approved protocol are non-inferior to new ones. Pacemaker reconditioning could enhance access to pacemaker therapy for patients who are unable to obtain a new device due to financial constraints. #AHA24 AHA Science

Reconditioned pacemaker devices using an FDA-approved protocol are non-inferior to new ones. Pacemaker reconditioning could enhance access to pacemaker therapy for patients who are unable to obtain a new device due to financial constraints. #AHA24 <a href="/AHAScience/">AHA Science</a>
Dr. Laxmi Mehta (@drlaxmimehta) 's Twitter Profile Photo

Intensive SBP lowering in people with Type 2 diabetes and elevated SBP could be beneficial for reducing cardiovascular events, but increased risks of hyperkalemia and symptomatic hypotension suggest the need for careful monitoring. #AHA24 AHA Science

Intensive SBP lowering in people with Type 2 diabetes and elevated SBP could be beneficial for reducing cardiovascular events, but increased risks of hyperkalemia and symptomatic hypotension suggest the need for careful monitoring. #AHA24 <a href="/AHAScience/">AHA Science</a>
Dr. Laxmi Mehta (@drlaxmimehta) 's Twitter Profile Photo

In pts with a history of ischemic cardiomyopathy & ventricular tachycardia, using a first-line catheter ablation procedure instead of anti-arrhythmic drug therapy resulted in reduction of composite endpoint, which included death or serious arrhythmia outcomes. #AHA24 AHA Science

In pts with a history of ischemic cardiomyopathy &amp; ventricular tachycardia, using a first-line catheter ablation procedure instead of anti-arrhythmic drug therapy resulted in reduction of composite endpoint, which included death or serious arrhythmia outcomes. #AHA24 <a href="/AHAScience/">AHA Science</a>
Dr. Laxmi Mehta (@drlaxmimehta) 's Twitter Profile Photo

OPTION Trial: LAAC resulted in sign less non-procedure-related major bleeding than OAC after catheter-based AF ablation.  Similar rates stroke, systemic embolism, or death observed btw groups.  LAAC could be safer alternative to OAC for stroke prevention. #AHA24 AHA Science

OPTION Trial: LAAC resulted in sign less non-procedure-related major bleeding than OAC after catheter-based AF ablation.  Similar rates stroke, systemic embolism, or death observed btw groups.  LAAC could be safer alternative to OAC for stroke prevention. #AHA24 <a href="/AHAScience/">AHA Science</a>
Jon Pagtakhan (@jonpheart) 's Twitter Profile Photo

Happening now: #ChicagoSTEMGoesRed + Council on Clinical Cardiology @ #AHA24 for our Students @ Sessions / High School Outreach Program. 100+ students are here for an immersive opportunity to consider a STEM career. The future of science & medicine looks bright! AHA Science

Happening now: #ChicagoSTEMGoesRed + Council on Clinical Cardiology @ #AHA24 for our Students @ Sessions / High School Outreach Program. 100+ students are here for an immersive opportunity to consider a STEM career. The future of science &amp; medicine looks bright! <a href="/AHAScience/">AHA Science</a>